SPC320
Ozanimod eða lyfjafræðilega viðunandi salt þar af, sérstaklega ozanimodvetnisklóríð
Status:
VeittApplication date:
18.11.2020Application published:
15.12.2020Grant published:
15.4.2025
Max expiry date:
24.5.2035Medicine name:
ZeposiaMedicine for children:
No
Timeline
Today
18.11.2020Application
15.12.2020Publication
15.4.2025Registration
24.5.2035Expires
Marketing license
IS authorization number:
EU/1/20/1442/001 & EU/1/20/1442/002-003Date:
22.6.2020
Foreign authorization number:
EU/1/20/1442Date:
20.5.2020
Owner
Name:
RECEPTOS LLCAddress:
Route 206 & Province Line Road, Princeton, New Jersey 08543 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2498610
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 27.12.2024